Please login to the form below

Not currently logged in
Email:
Password:

Dennis O'Brien

This page shows the latest Dennis O'Brien news and features for those working in and with pharma, biotech and healthcare.

Lucid Group acquires HealthCare21

Lucid Group acquires HealthCare21

Expands reach in UK, Asia Pacific and Middle East. From left to right: Cliff Wyatt, HealthCare21 managing director, Jan Steele, Lucid Group COO and co-founder and Dennis O’Brien, Lucid ... HealthCare21 brings further scientific and editorial expertise

Latest news

  • Lucid Group acquires digital and creative agency Bluedog Lucid Group acquires digital and creative agency Bluedog

    Bluedog brings a “key piece of the jigsaw” to Lucid, commented Lucid’s CEO Dennis O’Brien, referring to the company’s skills in digital design, motion graphics, video development and ... a “perfect match” says O’Brien.

  • Signal strength Signal strength

    The best communications programmes start by identifying the patient outcomes they want to improve and work backwards from there,” says Dennis O’Brien, CEO, Lucid Group. ... says Dennis O’Brien.

  • The Communiqué Awards at 20: Dennis O’Brien The Communiqué Awards at 20: Dennis OBrien

    Lucid's CEO on the Awards' enduring influence

  • Lucid strikes £11m investment deal with equity firm LDC Lucid strikes £11m investment deal with equity firm LDC

    Lucid’s founders Dennis O’Brien and Jan Steele will continue to lead the business. ... O’Brien said: “We felt the time was right to bring on board a strategic partner, and in LDC we have an experienced investor with a strong track record in the

  • The beauty and the beast of customer experience The beauty and the beast of customer experience

    It is hard to do this from the bottom up,” says Dennis O'Brien, CEO, Lucid Group. ... Dennis. “You need to understand what their current experience is, what their touchpoints are, what happens at those touchpoints and, ultimately, how can you improve

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Mapping the patient journey and minding the gap Mapping the patient journey and minding the gap

    We’re on an evolutionary journey with patient-centricity,” said Dennis O’Brien, CEO, Lucid Group. ... That focus, said Dennis, presents a huge opportunity to broaden the scope of patient- centricity.

  • The social dilemma: is it time for pharma to join the party?

    Welcome to the world of social media in pharma, 2019-style. The words of Dennis O’Brien, CEO at Lucid Group, provide a mischievous metaphor to which we can all relate: ... The question is: why? Pay to party. Dennis O'Brien. “Pharma isn’t yet

  • The first, my last, my everything The first, my last, my everything

    It’s making progress, but there’s a long way to go. “We’ve got to get much closer to patients,” said Dennis O’Brien, CEO, Lucid Group. ... We need to get over it.”. Progress, said Dennis, may require a fundamental shift in mindset.

  • Measures for measures Measures for measures

    Pharma widely accepts that it struggles to measure digital marketing effectiveness – but perhaps it’s starting from the wrong place,” said Dennis O’Brien, CEO, Lucid Group. ... said Dennis O’Brien.

  • Trust me, I’m from pharma Trust me, I’m from pharma

    compliance against regulation in the core areas where pharma has tripped up in the past, says Dennis O’Brien, CEO, Lucid Group.

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 40 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics